Decibel Therapeutics, Inc. Lease, Cost
Decibel Therapeutics, Inc. reported Lease, Cost of $1.59 million for the 6-month period ending 2023-06-30, per its 10-Q filed 2023-08-11.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LeaseCost · last filed 2023-08-11
- Decibel Therapeutics, Inc. lease, cost for the quarter ending 2023-06-30 was $847.00K, a 219.62% increase year-over-year.
- Decibel Therapeutics, Inc. lease, cost for the quarter ending 2023-03-31 was $747.00K, a 117.15% increase year-over-year.
- Decibel Therapeutics, Inc. lease, cost for the quarter ending 2022-12-31 was $584.00K.
- Decibel Therapeutics, Inc. lease, cost for the quarter ending 2022-09-30 was $262.00K.
- Decibel Therapeutics, Inc. lease, cost for fiscal 2022 was $1.46M.
| Period end | Lease, Cost 3 month | Lease, Cost 6 month | Lease, Cost 9 month | Lease, Cost 12 month |
|---|---|---|---|---|
| 2023-06-30 | $847.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | $1.59M 10-Q · filed 2023-08-11 | $2.18M derived: sum of 3 quarters · filed 2023-08-11 | $2.44M derived: sum of 4 quarters · filed 2023-08-11 |
| 2023-03-31 | $747.00K 10-Q · filed 2023-05-15 | $1.33M derived: sum of 2 quarters · filed 2023-05-15 | $1.59M derived: sum of 3 quarters · filed 2023-05-15 | $1.86M derived: sum of 4 quarters · filed 2023-08-11 |
| 2022-12-31 | $584.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | $846.00K derived: sum of 2 quarters · filed 2023-03-14 | $1.11M derived: sum of 3 quarters · filed 2023-08-11 | $1.46M 10-K · filed 2023-03-14 |
| 2022-09-30 | $262.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $527.00K derived: sum of 2 quarters · filed 2023-08-11 | $871.00K 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $265.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | $609.00K 10-Q · filed 2023-08-11 | ||
| 2022-03-31 | $344.00K 10-Q · filed 2023-05-15 |